Adastra Holdings Announces Resignation of Interim CEO, CFO, and Corporate Secretary
Langley, British Columbia–(Newsfile Corp. – September 26, 2024) – Adastra Holdings Ltd. (CSE: XTRX) (FSE: D2E) (“Adastra” or the “Company“), a leading cannabis processor and producer of two top Canadian concentrates brands, with a focus on product innovation and commercialization for adult-use and medical markets, today announces that Lachlan McLeod, Interim Chief Executive Officer, Chief Financial Officer, and Corporate Secretary, has resigned from his roles.
Mr. McLeod’s resignation as Interim CEO effective immediately, while he will remain in his roles as CFO and Corporate Secretary until November 25, 2024, to ensure a smooth transition and maintain continuity as the Company moves forward. The Company is currently in the process of selecting and approving new candidates to fill these roles.
“It has been an honour to lead Adastra through this dynamic period of development. I am confident that the Company is in a strong financial position for continued growth and success. I will work closely with the team to ensure a seamless transition and look forward to witnessing Adastra’s continued achievements,” said Lachlan McLeod, CEO, CFO, and Corporate Secretary of Adastra.
About Adastra Holdings Ltd.
Adastra has become one of Canada’s leaders in the supply and manufacturing of ethnobotanical and cannabis products for lawful adult-use. It serves medical markets and engages in forward-looking therapeutic applications. With cannabis concentrate products sold through retailers at more than 2,000 locations across Canada, Adastra’s Phyto Extractions and Endgame Extracts brands are now well established with a solid distribution presence. As a Health Canada licensed facility, it specializes in extraction, distillation and manufacturing of a range of cannabis-derived products. Adastra partners with healthcare professionals and practitioners within the regulated environment to create products suitable for the medical cannabis market, with the ultimate aim of addressing the needs of patients. For more information, visit: www.adastraholdings.ca.
Common shares of Adastra trade under the symbol XTRX on the Canadian Securities Exchange and under the symbol XTXXF on the OTC Pink Market.
On behalf of the Board of Directors,
Lachlan McLeod, CFO & Corporate Secretary
(778) 715 5011
For additional information, please contact:
(778) 715 5011
info@adastraholdings.ca